The Epidemiology Research Core (ERC) supports population-based cancer research in metropolitan Detroit. The ERC is grouped in the Population Research Core Cluster along with the Behavioral and Field Research Core. The ERC is located within the Metropolitan Detroit Cancer Surveillance System (MDCSS), an NCI-funded population-based Surveillance, Epidemiology and End Results (SEER) Program central cancer registry. The MDCSS is located at Wayne State University (WSU), under the umbrella of the Karmanos Cancer Institute (KCI). Both Detroit and national SEER data contain detailed histological and demographic information, primary treatment and survival data for all patients with newly-diagnosed, invasive cancer in their respective geographic coverage areas. The ERC provides necessary support for access to and utilization of the very complex local and national SEER data for research. The Core also provides epidemiology consulting and collaborates with KCI members conducting investigations in cancer prevention, etiology, treatment and outcomes. This mission is achieved through services including rapid case ascertainment; collection of medical records and biospecimens; abstracting medical records for study-specific information; linkage of datasets to patient data for diagnostic, treatment, and outcomes research; identifying population-based control populations; research support and training for studies involving participant recruitment and interviewing; data queries and epidemiologic expertise and collaboration in the conduct of population-based investigations of cancer. The ERC benefits KCI by centralizing access to SEER data and standardizing patient, physician and hospital interactions for studies using SEER data for population-based research. The metropolitan Detroit population contains a large number of minorities, with 22% of the ~25,000 annual cancer diagnoses in the SEER catchment area being African American. This makes the population ideal for the study of health disparities. The ERC contributes significantly to the population-based research conducted at KCI, primarily through the identification of eligible participants and collection of data and biospecimens on these participants, evidenced in part by the 91 publications accomplished with support of the ERC during the current grant period.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA022453-36
Application #
9384730
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2017-12-01
Budget End
2018-11-30
Support Year
36
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Herroon, Mackenzie K; Rajagurubandara, Erandi; Diedrich, Jonathan D et al. (2018) Adipocyte-activated oxidative and ER stress pathways promote tumor survival in bone via upregulation of Heme Oxygenase 1 and Survivin. Sci Rep 8:40
Colacino, Justin A; Azizi, Ebrahim; Brooks, Michael D et al. (2018) Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. Stem Cell Reports 10:1596-1609
Blocker, Stephanie J; Shields, Anthony F (2018) Imaging of Nanoparticle Distribution to Assess Treatments That Alter Delivery. Mol Imaging Biol 20:340-351
Guastella, Anthony R; Michelhaugh, Sharon K; Klinger, Neil V et al. (2018) Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors. J Neurooncol 139:239-249
Li, Feng; Wang, Yongli; Li, Dapeng et al. (2018) Perspectives on the recent developments with green tea polyphenols in drug discovery. Expert Opin Drug Discov 13:643-660
Ramseyer, Vanesa D; Kimler, Victoria A; Granneman, James G (2018) Vacuolar protein sorting 13C is a novel lipid droplet protein that inhibits lipolysis in brown adipocytes. Mol Metab 7:57-70
Healy, Mark A; Morris, Arden M; Abrahamse, Paul et al. (2018) The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program. BMC Cancer 18:481
Lacher, Sarah E; Alazizi, Adnan; Wang, Xuting et al. (2018) A hypermorphic antioxidant response element is associated with increased MS4A6A expression and Alzheimer's disease. Redox Biol 14:686-693
Alsaab, Hashem O; Sau, Samaresh; Alzhrani, Rami M et al. (2018) Tumor hypoxia directed multimodal nanotherapy for overcoming drug resistance in renal cell carcinoma and reprogramming macrophages. Biomaterials 183:280-294
Chammaa, May; Malysa, Agnes; Redondo, Carlos et al. (2018) RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer. J Cell Physiol 233:9548-9562

Showing the most recent 10 out of 826 publications